Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1144183

	registered interest
	date	03/09/2019
	answering body	Treasury
	answering dept id	14
	answering dept short name	Treasury
	answering dept sort name	Treasury
	hansard heading	Business: Investment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the Office for Budget Responsibility's (OBR) model for forecasting business investment, in the light of business investment growth consistently falling below OBR forecasts and remaining “significantly weaker than expected” according to its Economic and Fiscal Outlook, published in March.
	tabling member printed	Lord Mendelsohn
	uin	HL17671
	answer	answer is ministerial correction date of answer 09/09/2019 answer text The independent Office for Budget Responsibility (OBR) publishes an annual Forecast Evaluation Report, in which they compare their forecasts to subsequent published data, explain any forecast errors, and identify lessons for future forecasts. answering member printed The Earl of Courtown question first answered 09/09/2019 15:37:41 answering member 3359 label Biography information for The Earl of Courtown
	tabling member	4286 label Biography information for Lord Mendelsohn

1330362

	registered interest
	date	07/06/2021
	answering body	Treasury
	answering dept id	14
	answering dept short name	Treasury
	answering dept sort name	Treasury
	hansard heading	Cryptocurrencies: Environment Protection
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the level of energy use in the mining of Bitcoin, as identified by the Cambridge Bitcoin Electricity Consumption Index; and what steps they will take to address the environmental harms of cryptocurrencies.
	tabling member printed	Lord Mendelsohn
	uin	HL789
	answer	answer is ministerial correction date of answer 16/06/2021 answer text The Government has been monitoring developments within the cryptoasset industry, including rising energy usage.<p> </p><p>The Cryptoasset Taskforce, comprising HM Treasury, the Financial Conduct Authority, and the Bank of England, considers the impact of cryptoassets and assesses what, if any, regulation is required in response. The Government stands ready to respond to emerging risks or changes in the market and will continue to monitor developments in cryptoassets.</p><p> </p><p>In November 2020, the Chancellor announced that the UK will implement a green taxonomy – a common framework for determining which activities can be defined as environmentally sustainable – which will improve understanding of the impact of firms’ activities and investments on the environment and support our transition to a sustainable economy. More details on the green taxonomy will be announced in due course.</p>The Government has already taken action to ensure the UK is the world-leading centre for green finance including through announcing an intention to make disclosures aligned with the Taskforce on Climate-related Financial Disclosures (TCFD) fully mandatory across the economy by 2025, making the UK the first country to do so. answering member printed Lord Agnew of Oulton grouped question UIN HL787 HL788 question first answered 16/06/2021 10:45:08 answering member 4689 label Biography information for Lord Agnew of Oulton
	tabling member	4286 label Biography information for Lord Mendelsohn

1330361

	registered interest
	date	07/06/2021
	answering body	Treasury
	answering dept id	14
	answering dept short name	Treasury
	answering dept sort name	Treasury
	hansard heading	Cryptocurrencies: Environment Protection
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether (1) the Cryptoasset Taskforce, or (2) any government department, collects or collates data on the environmental impact of cryptocurrencies; and if so, when any such data will be published.
	tabling member printed	Lord Mendelsohn
	uin	HL788
	answer	answer is ministerial correction date of answer 16/06/2021 answer text The Government has been monitoring developments within the cryptoasset industry, including rising energy usage.<p> </p><p>The Cryptoasset Taskforce, comprising HM Treasury, the Financial Conduct Authority, and the Bank of England, considers the impact of cryptoassets and assesses what, if any, regulation is required in response. The Government stands ready to respond to emerging risks or changes in the market and will continue to monitor developments in cryptoassets.</p><p> </p><p>In November 2020, the Chancellor announced that the UK will implement a green taxonomy – a common framework for determining which activities can be defined as environmentally sustainable – which will improve understanding of the impact of firms’ activities and investments on the environment and support our transition to a sustainable economy. More details on the green taxonomy will be announced in due course.</p>The Government has already taken action to ensure the UK is the world-leading centre for green finance including through announcing an intention to make disclosures aligned with the Taskforce on Climate-related Financial Disclosures (TCFD) fully mandatory across the economy by 2025, making the UK the first country to do so. answering member printed Lord Agnew of Oulton grouped question UIN HL787 HL789 question first answered 16/06/2021 10:45:08 answering member 4689 label Biography information for Lord Agnew of Oulton
	tabling member	4286 label Biography information for Lord Mendelsohn

1330360

	registered interest
	date	07/06/2021
	answering body	Treasury
	answering dept id	14
	answering dept short name	Treasury
	answering dept sort name	Treasury
	hansard heading	Bitcoin: Energy
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government, further to the establishment of the Bitcoin Mining Council, what steps they will take (1) to encourage the use of renewable power and sustainable Bitcoin mining, and (2) to monitor the effectiveness of the Council.
	tabling member printed	Lord Mendelsohn
	uin	HL787
	answer	answer is ministerial correction date of answer 16/06/2021 answer text The Government has been monitoring developments within the cryptoasset industry, including rising energy usage.<p> </p><p>The Cryptoasset Taskforce, comprising HM Treasury, the Financial Conduct Authority, and the Bank of England, considers the impact of cryptoassets and assesses what, if any, regulation is required in response. The Government stands ready to respond to emerging risks or changes in the market and will continue to monitor developments in cryptoassets.</p><p> </p><p>In November 2020, the Chancellor announced that the UK will implement a green taxonomy – a common framework for determining which activities can be defined as environmentally sustainable – which will improve understanding of the impact of firms’ activities and investments on the environment and support our transition to a sustainable economy. More details on the green taxonomy will be announced in due course.</p>The Government has already taken action to ensure the UK is the world-leading centre for green finance including through announcing an intention to make disclosures aligned with the Taskforce on Climate-related Financial Disclosures (TCFD) fully mandatory across the economy by 2025, making the UK the first country to do so. answering member printed Lord Agnew of Oulton grouped question UIN HL788 HL789 question first answered 16/06/2021 10:45:07 answering member 4689 label Biography information for Lord Agnew of Oulton
	tabling member	4286 label Biography information for Lord Mendelsohn

1385194

	registered interest
	date	06/12/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Immunotherapy: Shortages
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what communications have been issued by the NHS in England about the immunoglobulin shortage to patient groups supporting people with immunodeficiency; and whether the NHS in England has communicated directly with patients to explain the situation and how it will affect them.
	tabling member printed	Lord Mendelsohn
	uin	HL4726
	answer	answer is ministerial correction date of answer 20/12/2021 answer text <p>With the input of clinicians, professional bodies and patient groups, NHS England and NHS Improvement and the UK Primary Immunodeficiency Network have developed a patient information leaflet which was issued to National Health Service trusts on 8 November 2021, with a request to discuss and share with patients as part of individual clinical conversations. NHS England and NHS Improvement have also shared the leaflet with patient groups to circulate to affected members.</p><p>The patient information leaflet highlights that, due to the COVID-19 pandemic, fewer people have been able to donate blood, which has impacted the availability of immunoglobulin products both globally and in the United Kingdom. The patient information leaflet also explains what the impact of the global shortage of immunoglobulin products may mean for UK patients and how they can access support. A copy of the patient leaflet, <em>Immunoglobulin replacement therapy: Information for patients from the NHS and the UK Primary Immunodeficiency Network</em> is attached.</p> answering member printed Lord Kamall question first answered 20/12/2021 13:19:29 answering member 4909 label Biography information for Lord Kamall attachment 1 file name B0910_ii_Immunoglobulin - patient information leaflet_041121.docx title Immunoglobulin replacement therapy: Information fo
	tabling member	4286 label Biography information for Lord Mendelsohn

1437285

	registered interest
	date	01/03/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Disease Control
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans, if any, they have to work with charities that represent clinically extremely vulnerable people to ensure that these groups rapidly receive communications concerning their risk from COVID-19 as restrictions and mandatory isolation comes to an end on 1 April.
	tabling member printed	Lord Mendelsohn
	uin	HL6546
	answer	answer is ministerial correction date of answer 15/03/2022 answer text <p>We will continue to meet with charities and stakeholders representing those whose immune system means they are at higher risk of serious illness from COVID-19. The Chief Executive of the UK Health Security Agency, Dr Jenny Harries, is the clinical lead for the programmes supporting these patients and has met with charities at stakeholder engagement sessions.</p> answering member printed Lord Kamall question first answered 15/03/2022 12:07:32 answering member 4909 label Biography information for Lord Kamall
	tabling member	4286 label Biography information for Lord Mendelsohn

1462730

	registered interest
	date	12/05/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Evusheld
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government why they have not recognised the laboratory assay tests conducted in (1) the US, and (2) the EU, on Evusheld against Omicron subvariants.
	tabling member printed	Lord Mendelsohn
	uin	HL215
	answer	answer is ministerial correction date of answer 25/05/2022 answer text <p>We understand that the United States of America has increased the suggested dose of Evusheld, in line with in vitro results showing that Evusheld has reduced efficacy against some Omicron subvariants. The Food and Drug Administration’s in vitro data was pseudovirus data, whereas the tests being conducted by the UK Health Security Agency (UKHSA) are based on live virus data. The European Medicines Agency has acknowledged the possibility that Evusheld has reduced efficacy against Omicron subvariants, based on laboratory studies. The data generated by the UKHSA will enhance our understanding of the effectiveness of Evusheld's neutralisation of Omicron subvariants, including BA.2.</p> answering member printed Lord Kamall question first answered 25/05/2022 11:30:45 answering member 4909 label Biography information for Lord Kamall
	tabling member	4286 label Biography information for Lord Mendelsohn

1464289

	registered interest
	date	18/05/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Disease Control
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government who is responsible for leading the COVID-19 enhanced protection programme (EPP); and what is the process for (1) charities, and (2) patient organisations, to be designated as stakeholders for the programme.
	tabling member printed	Lord Mendelsohn
	uin	HL349
	answer	answer is ministerial correction date of answer 06/06/2022 answer text <p>We regularly engage with charities and patient organisation representing and supporting immunocompromised and immunosuppressed people. Further to discussions with these groups, we are establishing an engagement forum for charities and patient organisations to discuss issues relating to the enhanced protection programme and to seek the views of these stakeholders in advance of any updates to guidance. We will continue to update these stakeholders on the enhanced protection programme through webinars, meetings and correspondence.</p><p> </p><p>The enhanced protection programme is a tripartite scheme administered by the Department, NHS England and NHS Improvement and the UK Health Security Agency (UKHSA). Dame Jenny Harries, the Chief Executive of the UKHSA, is the senior responsible owner for the</p><p>programme. There is no formal process for designating patient organisations as stakeholders for the programme.</p> answering member printed Lord Kamall grouped question UIN HL347 HL348 question first answered 06/06/2022 10:59:57 answering member 4909 label Biography information for Lord Kamall
	tabling member	4286 label Biography information for Lord Mendelsohn

1464288

	registered interest
	date	18/05/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Disease Control
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans they have to (1) communicate, and (2) consult, with (a) charities, and (b) patient organisations, as part of the COVID-19 enhanced protection programme (EPP); and what format this will take.
	tabling member printed	Lord Mendelsohn
	uin	HL348
	answer	answer is ministerial correction date of answer 06/06/2022 answer text <p>We regularly engage with charities and patient organisation representing and supporting immunocompromised and immunosuppressed people. Further to discussions with these groups, we are establishing an engagement forum for charities and patient organisations to discuss issues relating to the enhanced protection programme and to seek the views of these stakeholders in advance of any updates to guidance. We will continue to update these stakeholders on the enhanced protection programme through webinars, meetings and correspondence.</p><p> </p><p>The enhanced protection programme is a tripartite scheme administered by the Department, NHS England and NHS Improvement and the UK Health Security Agency (UKHSA). Dame Jenny Harries, the Chief Executive of the UKHSA, is the senior responsible owner for the</p><p>programme. There is no formal process for designating patient organisations as stakeholders for the programme.</p> answering member printed Lord Kamall grouped question UIN HL347 HL349 question first answered 06/06/2022 10:59:57 answering member 4909 label Biography information for Lord Kamall
	tabling member	4286 label Biography information for Lord Mendelsohn

1464287

	registered interest
	date	18/05/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Disease Control
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government, further to the Written Answer by Lord Kamall on 27 April (HL7561), what conclusions they have reached following meetings with groups representing the immunocompromised community on how they can be involved in (1) creating, and (2) disseminating, (a) communication, and (b) guidance, to people about how to safely manage their ongoing risk.
	tabling member printed	Lord Mendelsohn
	uin	HL347
	answer	answer is ministerial correction date of answer 06/06/2022 answer text <p>We regularly engage with charities and patient organisation representing and supporting immunocompromised and immunosuppressed people. Further to discussions with these groups, we are establishing an engagement forum for charities and patient organisations to discuss issues relating to the enhanced protection programme and to seek the views of these stakeholders in advance of any updates to guidance. We will continue to update these stakeholders on the enhanced protection programme through webinars, meetings and correspondence.</p><p> </p><p>The enhanced protection programme is a tripartite scheme administered by the Department, NHS England and NHS Improvement and the UK Health Security Agency (UKHSA). Dame Jenny Harries, the Chief Executive of the UKHSA, is the senior responsible owner for the</p><p>programme. There is no formal process for designating patient organisations as stakeholders for the programme.</p> answering member printed Lord Kamall grouped question UIN HL348 HL349 question first answered 06/06/2022 10:59:57 answering member 4909 label Biography information for Lord Kamall
	tabling member	4286 label Biography information for Lord Mendelsohn